Molecular dissection of antibody responses against pneumococcal surface protein A: Evidence for diverse DH-less heavy chain gene usage and avidity maturation

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5570-5585

  Rohatgi, Soma ^a   Dutta, Debjani ^a   Tahir, Suhail ^a,b   Sehgal, Devinder ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; IMMUNOGLOBULIN G ANTIBODY; PALINDROMIC DNA; PNEUMOCOCCAL SURFACE PROTEIN A; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; EPITOPE; IMMUNOGLOBULIN HEAVY CHAIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; CLONE; CODON; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; GENE EXPRESSION; GENE MUTATION; HEAVY CHAIN; HYBRIDOMA; IMMUNIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; STREPTOCOCCUS PNEUMONIAE; UNINDEXED SEQUENCE; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BIOSYNTHESIS; CBA MOUSE; GENE DELETION; GENE REARRANGEMENT; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY DIVERSITY; BACTERIAL PROTEINS; BASE SEQUENCE; EPITOPES, B-LYMPHOCYTE; FEMALE; GENE DELETION; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HYBRIDOMAS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; STREPTOCOCCUS PNEUMONIAE;

EID: 66949114040     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803254     Document Type: Article

References (56)

1. World Health Organization. 2007. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly. Epidemiol. Rec 82: 93-104.
2. Tai, S. S. 2006. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit. Rev. Microbiol. 32: 139-153.
3. Giefing, C., A. L. Meinke, M. Hanner, T. Henics, M. D. Bui, D. Gelbmann, U. Lundberg, B. M. Senn, M. Schunn, A. Habel, et al. 2008. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J. Exp. Med. 205: 117-131. (Pubitemid 351185720)
4. Kadioglu, A., J. N. Weiser, J. C. Paton, and P. W. Andrew. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6: 288-301. (Pubitemid 351404773)
5. Briles, D. E., S. K. Hollingshead, J. C. Paton, E. W. Ades, L. Novak, F. W. van Ginkel, and W. H. Benjamin, Jr. 2003. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188: 339-348.
6. Tart, R. C., L. S. McDaniel, B. A. Ralph, and D. E. Briles. 1996. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J. Infect. Dis. 173: 380-386.
7. Briles, D. E., J. D. King, M. A. Gray, L. S. McDaniel, E. Swiatlo, and K. A. Benton. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14: 858-867.
8. Briles, D. E., S. K. Hollingshead, G. S. Nabors, J. C. Paton, and A. Brooks-Walter. 2000. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 19(Suppl 1): S87-S95.
9. Roche, H., A. Hakansson, S. K. Hollingshead, and D. E. Briles. 2003. Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect. Immun. 71: 1033-1041. (Pubitemid 36254282)
10. Roche, H., B. Ren, L. S. McDaniel, A. Hakansson, and D. E. Briles. 2003. Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae. Infect. Immun. 71: 4498-4505. (Pubitemid 36919916)
11. Nabors, G. S., P. A. Braun, D. J. Herrmann, M. L. Heise, D. J. Pyle, S. Gravenstein, M. Schilling, L. M. Ferguson, S. K. Hollingshead, D. E. Briles, and R. S. Becker. 2000. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 18: 1743-1754.
12. Briles, D. E., S. K. Hollingshead, J. King, A. Swift, P. A. Braun, M. K. Park, L. M. Ferguson, M. H. Nahm, and G. S. Nabors. 2000. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J. Infect. Dis. 182: 1694-1701.
13. Ochs, M. M., W. Bartlett, D. E. Briles, B. Hicks, A. Jurkuvenas, P. Lau, B. Ren, and A. Millar. 2008. Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae. Microb. Pathog. 44: 204-214.
14. Ren, B., A. J. Szalai, S. K. Hollingshead, and D. E. Briles. 2004. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect. Immun. 72: 114-122. (Pubitemid 38018168)
15. Shaper, M., S. K. Hollingshead, W. H. Benjamin, Jr., and D. E. Briles. 2004. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin (corrected). Infect. Immun. 72: 5031-5040. (Pubitemid 39223387)
16. Yother, J., and J. M. White. 1994. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176: 2976-2985. (Pubitemid 24152944)
17. Yother, J., and D. E. Briles. 1992. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bacteriol. 174: 601-609.
18. Hollingshead, S. K., R. Becker, and D. E. Briles. 2000. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 68: 5889-5900.
19. Mollerach, M., M. Regueira, L. Bonofiglio, R. Callejo, J. Pace, J. L. Di Fabio, S. Hollingshead, and D. Briles. 2004. Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol. Infect. 132: 177-184. (Pubitemid 38444599)
20. Vela Coral, M. C., N. Fonseca, E. Castaneda, J. L. Di Fabio, S. K. Hollingshead, and D. E. Briles. 2001. Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children. Emerg. Infect. Dis. 7: 832-836. (Pubitemid 33121589)
21. McDaniel, L. S., B. A. Ralph, D. O. McDaniel, and D. E. Briles. 1994. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb. Pathog. 17: 323-337.
22. Kolberg, J., A. Aase, T. E. Michaelsen, and G. Rodal. 2001. Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates. FEMS Immunol. Med. Microbiol. 31: 175-180. (Pubitemid 33086751)
23. Kolberg, J., A. Aase, G. Rodal, J. E. Littlejohn, and M. J. Jedrzejas. 2003. Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling. FEMS Immunol. Med. Microbiol. 39: 265-273. (Pubitemid 37461006)
24. Wu, Z. Q., Y. Shen, A. Q. Khan, C. L. Chu, R. Riese, H. A. Chapman, O. Kanagawa, and C. M. Snapper. 2002. The mechanism underlying T cell help for induction of an antigen-specific in vivo humoral immune response to intact Streptococcus pneumoniae is dependent on the type of antigen. J. Immunol. 168: 5551-5557.
25. Galfre, G., and C. Milstein. 1981. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 73: 3-46.
26. Rohatgi, S., P. Ganju, and D. Sehgal. 2008. Systematic design and testing of nested (RT-)PCR primers for specific amplification of mouse rearranged/expressed immunoglobulin variable region genes from small number of B cells. J. Immunol. Methods 339: 205-219.
27. Lefranc, M. P., V. Giudicelli, Q. Kaas, E. Duprat, J. Jabado-Michaloud, D. Scaviner, C. Ginestoux, O. Clement, D. Chaume, and G. Lefranc. 2005. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33: D593-D597.
28. Kabat, E. A., T. T. Wu, H. M. Perry, K. S. Gotterman, and C. Foeller, C. 1991. Sequences of Proteins of Immunological Interest, 5th Ed. U.S. Department of Health and Human Services, Bethesda, MD.
29. Rath, S., C. M. Stanley, and M. W. Steward. 1988. An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J. Immunol. Methods 106: 245-249. (Pubitemid 18054251)
30. Devey, M. E., K. Bleasdale, S. Lee, and S. Rath. 1988. Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J. Immunol. Methods 106: 119-125.
31. Devey, M. E., K. M. Bleasdale-Barr, P. Bird, and P. L. Amlot. 1990. Antibodies of different human IgG subclasses show distinct patterns of affinity maturation after immunization with keyhole limpet haemocyanin. Immunology 70: 168-174.
32. van Dam, G. J., A. F. Verheul, G. J. Zigterman, M. J. de Reuver, and H. Snippe. 1989. Estimation of the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 by inhibition ELISA. Mol. Immunol. 26: 269-274.
33. Huang, H., R. Zhou, H. Fan, H. Dan, M. Chen, L. Yan, W. Bei, and H. Chen. 2006. Generation of monoclonal antibodies and epitope mapping of ApxIVA of Actinobacillus pleuropneumoniae. Mol. Immunol. 43: 2130-2134.
34. Persson, M. A., S. E. Brown, M. W. Steward, L. Hammarstrom, C. I. Smith, C. R. Howard, M. Wahl, B. Rynnel-Dagoo, G. Lefranc, and A. O. Carbonara. 1988. IgG subclass-associated affinity differences of specific antibodies in humans. J. Immunol. 140: 3875-3879.
35. Lossos, I. S., R. Tibshirani, B. Narasimhan, and R. Levy. 2000. The inference of antigen selection on Ig genes. J. Immunol. 165: 5122-5126.
36. Schelonka, R. L., J. Tanner, Y. Zhuang, G. L. Gartland, M. Zemlin, and H. W. Schroeder, Jr. 2007. Categorical selection of the antibody repertoire in splenic B cells. Eur. J. Immunol. 37: 1010-1021.
37. Darrieux, M., A. T. Moreno, D. M. Ferreira, F. C. Pimenta, A. L. de Andrade, A. P. Lopes, L. C. Leite, and E. N. Miyaji. 2008. Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J. Med. Microbiol. 57: 273-278. (Pubitemid 351358529)
38. Bogaert, D., P. W. Hermans, P. V. Adrian, H. C. Rumke, and R. de Groot. 2004. Pneumococcal vaccines: an update on current strategies. Vaccine 22: 2209-2220. (Pubitemid 38626060)
39. Tao, W., and A. L. Bothwell. 1990. Development of B cell lineages during a primary anti-hapten immune response. J. Immunol. 145: 3216-3222.
40. Cumano, A., and K. Rajewsky. 1986. Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP. EMBO J. 5: 2459-2468.
41. Solin, M. L., M. Kaartinen, and O. Makela. 1992. The same few V genes account for a majority of oxazolone antibodies in most mouse strains. Mol. Immunol. 29: 1357-1362.
42. White, H., and D. Gray. 2000. Analysis of immunoglobulin (Ig) isotype diversity and IgM/D memory in the response to phenyl-oxazolone. J. Exp. Med. 191: 2209-2220. (Pubitemid 30416366)
43. Busto, P., R. Gerstein, L. Dupre, C. A. Giorgetti, E. Selsing, and J. L. Press. 1987. Molecular analysis of heavy and light chains used by primary and secondary anti-(T,G)-A-L antibodies produced by normal and Xid mice. J. Immunol. 139: 608-618. (Pubitemid 17104066)
44. Press, J. L., and C. A. Giorgetti. 1986. Clonal analysis of the primary and secondary B cell responses of neonatal, adult, and Xid mice to (T,G)-A-L. J. Immunol. 137: 784-790.
45. Claflin, J. L., and J. Berry. 1988. Genetics of the phosphocholine- specific anti-body response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected. J. Immunol. 141: 4012-4019.
46. Baxendale, H. E., Z. Davis, H. N. White, M. B. Spellerberg, F. K. Stevenson, and D. Goldblatt. 2000. Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Eur. J. Immunol. 30: 1214-1223. (Pubitemid 30216239)
47. Schroeder, H. W., Jr., G. C. Ippolito, and S. Shiokawa. 1998. Regulation of the antibody repertoire through control of HCDR3 diversity. Vaccine 16: 1383-1390.
48. Raaphorst, F. M., C. S. Raman, B. T. Nall, and J. M. Teale. 1997. Molecular mechanisms governing reading frame choice of immunoglobulin diversity genes. Immunol. Today 18: 37-43.
49. Ippolito, G. C., R. L. Schelonka, M. Zemlin, I. I. Ivanov, R. Kobayashi, C. Zemlin, G. L. Gartland, L. Nitschke, J. Pelkonen, K. Fujihashi, et al. 2006. Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J. Exp. Med. 203: 1567-1578.
50. Maizels, N., and A. Bothwell. 1985. The T-cell-independent immune response to the hapten NP uses a large repertoire of heavy chain genes. Cell 43: 715-720. (Pubitemid 16090709)
51. Morzycka-Wroblewska, E., F. E. Lee, and S. V. Desiderio. 1988. Unusual immunoglobulin gene rearrangement leads to replacement of recombinational signal sequences. Science 242: 261-263.
52. Koralov, S. B., T. I. Novobrantseva, K. Hochedlinger, R. Jaenisch, and K. Rajewsky. 2005. Direct in vivo VH to JH rearrangement violating the 12/23 rule. J. Exp. Med. 201: 341-348.
53. Clarke, S. H., L. M. Staudt, J. Kavaler, D. Schwartz, W. U. Gerhard, and M. G. Weigert. 1990. V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. J. Immunol. 144: 2795-2801.
54. McKee, A. S., M. W. Munks, and P. Marrack. 2007. How do adjuvants work? Important considerations for new generation adjuvants. Immunity 27: 687-690.
55. Klinman, D. M., H. Xie, S. F. Little, D. Currie, and B. E. Ivins. 2004. CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques. Vaccine 22: 2881-2886.
56. Siegrist, C. A., M. Pihlgren, C. Tougne, S. M. Efler, M. L. Morris, M. J. AlAdhami, D. W. Cameron, C. L. Cooper, J. Heathcote, H. L. Davis, and P. H. Lambert. 2004. Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine 23: 615-622.